SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (345)1/8/2001 10:21:44 AM
From: tuck  Read Replies (1) of 1784
 
QGENF getting whacked today. I think a possible warning must be getting priced in, or that psychology is changing (thanks to the Cramers of the world) in such a way that investors want lower P/Es. It certainly isn't this:

siliconinvestor.com

A perfectly harmless piece of news. Trickle has a couple of stocks now below their secondary or tertiary nibble targets. However, Trickle will wait. Several high-flyers Trickle has been lusting after are approaching nibble targets, and it would rather own those at lower cost than the impatient first buys of these companies: IVGN, ABI, & WAT (currently not owned). Targets for all of these is $55.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext